Extended Varenicline for Smoking Cessation: A Pilot Study
This pilot study will utilize a two group randomized design. Adult smokers who are motivated
to quit smoking will be randomized to one of two treatment groups. Both groups will receive
brief support counseling. During a one-week baseline and the 4-week pre-quit period smoking
rate, smoking satisfaction, withdrawal, and craving will be assessed on a daily basis.
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Changes in smoking behavior, as well as smoking satisfaction, craving, and withdrawal.
Martin C Mahoney, MD, PhD
Roswell Park Cancer Institute
United States: Institutional Review Board
|Roswell Park Cancer Institute||Buffalo, New York 14263|